|
New Diabetes Drugs: With the current epidemic of diabetes, pharmaceutical companies are discovering diabetes treatments in new drug classes; DPP-4 inhibitors, GLP-1 analogues, and SGLT2 Inhibitors are in clinical trials or waiting for FDA approval.
Hematology Library , Alternative Remedies Library
|
|